BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 10594012)

  • 1. Auto-inhibition and partner proteins, core-binding factor beta (CBFbeta) and Ets-1, modulate DNA binding by CBFalpha2 (AML1).
    Gu TL; Goetz TL; Graves BJ; Speck NA
    Mol Cell Biol; 2000 Jan; 20(1):91-103. PubMed ID: 10594012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Auto-inhibition of Ets-1 is counteracted by DNA binding cooperativity with core-binding factor alpha2.
    Goetz TL; Gu TL; Speck NA; Graves BJ
    Mol Cell Biol; 2000 Jan; 20(1):81-90. PubMed ID: 10594011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The leukemic protein core binding factor beta (CBFbeta)-smooth-muscle myosin heavy chain sequesters CBFalpha2 into cytoskeletal filaments and aggregates.
    Adya N; Stacy T; Speck NA; Liu PP
    Mol Cell Biol; 1998 Dec; 18(12):7432-43. PubMed ID: 9819429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Core-binding factor beta (CBFbeta), but not CBFbeta-smooth muscle myosin heavy chain, rescues definitive hematopoiesis in CBFbeta-deficient embryonic stem cells.
    Miller JD; Stacy T; Liu PP; Speck NA
    Blood; 2001 Apr; 97(8):2248-56. PubMed ID: 11290585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical and biophysical properties of the core-binding factor alpha2 (AML1) DNA-binding domain.
    Crute BE; Lewis AF; Wu Z; Bushweller JH; Speck NA
    J Biol Chem; 1996 Oct; 271(42):26251-60. PubMed ID: 8824275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The RUNX1 Runt domain at 1.25A resolution: a structural switch and specifically bound chloride ions modulate DNA binding.
    Bäckström S; Wolf-Watz M; Grundström C; Härd T; Grundström T; Sauer UH
    J Mol Biol; 2002 Sep; 322(2):259-72. PubMed ID: 12217689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CBFbeta allosterically regulates the Runx1 Runt domain via a dynamic conformational equilibrium.
    Yan J; Liu Y; Lukasik SM; Speck NA; Bushweller JH
    Nat Struct Mol Biol; 2004 Sep; 11(9):901-6. PubMed ID: 15322525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The CBFbeta subunit is essential for CBFalpha2 (AML1) function in vivo.
    Wang Q; Stacy T; Miller JD; Lewis AF; Gu TL; Huang X; Bushweller JH; Bories JC; Alt FW; Ryan G; Liu PP; Wynshaw-Boris A; Binder M; Marín-Padilla M; Sharpe AH; Speck NA
    Cell; 1996 Nov; 87(4):697-708. PubMed ID: 8929538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Energetic and functional contribution of residues in the core binding factor beta (CBFbeta ) subunit to heterodimerization with CBFalpha.
    Tang YY; Shi J; Zhang L; Davis A; Bravo J; Warren AJ; Speck NA; Bushweller JH
    J Biol Chem; 2000 Dec; 275(50):39579-88. PubMed ID: 10984496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural analyses of DNA recognition by the AML1/Runx-1 Runt domain and its allosteric control by CBFbeta.
    Tahirov TH; Inoue-Bungo T; Morii H; Fujikawa A; Sasaki M; Kimura K; Shiina M; Sato K; Kumasaka T; Yamamoto M; Ishii S; Ogata K
    Cell; 2001 Mar; 104(5):755-67. PubMed ID: 11257229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional mutagenesis of AML1/RUNX1 and PEBP2 beta/CBF beta define distinct, non-overlapping sites for DNA recognition and heterodimerization by the Runt domain.
    Nagata T; Werner MH
    J Mol Biol; 2001 Apr; 308(2):191-203. PubMed ID: 11327761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutual activation of Ets-1 and AML1 DNA binding by direct interaction of their autoinhibitory domains.
    Kim WY; Sieweke M; Ogawa E; Wee HJ; Englmeier U; Graf T; Ito Y
    EMBO J; 1999 Mar; 18(6):1609-20. PubMed ID: 10075931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptional activation of a retrovirus enhancer by CBF (AML1) requires a second factor: evidence for cooperativity with c-Myb.
    Zaiman AL; Lenz J
    J Virol; 1996 Aug; 70(8):5618-29. PubMed ID: 8764076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biophysical characterization of interactions between the core binding factor alpha and beta subunits and DNA.
    Tang YY; Crute BE; Kelley JJ; Huang X; Yan J; Shi J; Hartman KL; Laue TM; Speck NA; Bushweller JH
    FEBS Lett; 2000 Mar; 470(2):167-72. PubMed ID: 10734228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutagenesis of the Runt domain defines two energetic hot spots for heterodimerization with the core binding factor beta subunit.
    Zhang L; Li Z; Yan J; Pradhan P; Corpora T; Cheney MD; Bravo J; Warren AJ; Bushweller JH; Speck NA
    J Biol Chem; 2003 Aug; 278(35):33097-104. PubMed ID: 12807883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular basis for a dominant inactivation of RUNX1/AML1 by the leukemogenic inversion 16 chimera.
    Huang G; Shigesada K; Wee HJ; Liu PP; Osato M; Ito Y
    Blood; 2004 Apr; 103(8):3200-7. PubMed ID: 15070703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The highly conserved beta-hairpin of the paired DNA-binding domain is required for assembly of Pax-Ets ternary complexes.
    Wheat W; Fitzsimmons D; Lennox H; Krautkramer SR; Gentile LN; McIntosh LP; Hagman J
    Mol Cell Biol; 1999 Mar; 19(3):2231-41. PubMed ID: 10022910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural coupling of the inhibitory regions flanking the ETS domain of murine Ets-1.
    Skalicky JJ; Donaldson LW; Petersen JM; Graves BJ; McIntosh LP
    Protein Sci; 1996 Feb; 5(2):296-309. PubMed ID: 8745408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of AML1/Runx1 in the pathogenesis of hematological malignancies.
    Kurokawa M; Hirai H
    Cancer Sci; 2003 Oct; 94(10):841-6. PubMed ID: 14556655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure and backbone dynamics of Apo-CBFbeta in solution.
    Wolf-Watz M; Grundström T; Härd T
    Biochemistry; 2001 Sep; 40(38):11423-32. PubMed ID: 11560490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.